Adult Congenital Heart Disease
15
9
10
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
13%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (15)
HIIT Versus Moderate Continuous Training in ACHD
Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease
AI-Enabled Frailty Risk Prediction in Adult Congenital Heart Disease
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease
MINDS Imaging Ancillary Study
Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease
Real-World Data on the Effects of Cardiac Resynchronization Therapy in Adult Patients With Congenital Heart Disease
Observational Cohort Study of Adult Patients With Congenital Heart Disease
Search for Noninvasive Markers of "Graft Injury" in Pediatric and Adult Patients With Congenital Heart Disease Undergoing Cardiac Transplantation
Should we Avoid Performing Invasive Coronary Angiography Before Cardiac Surgery in ACHD Patients?
Prognosis in Adult Patients with Congenital Heart Disease
Multicenter Validation of a Predictor Model of ACHD Patients and Cardiac Surgery
Comparison of Home and Standard Clinic Monitoring of INR in Patients With CHD